Skip to Main Content

Paper Details

Systemic Immune Dysfunction in Cancer Patients Driven by IL6 Induction of LAG3 in Peripheral CD8+ T Cells.
Cancer Immunol Res
7
2022
ADAM10, CD8, CD8+, CD8+ T cells, CD8+ T-cell, CD8+ T-cell dysfunction, Cancer, IL6, IRs, Immune Dysfunction, LAG3, LAG3IC, LAG3SUR, PD1, Patients, Peripheral CD8+ T Cells, STAT3, Systemic immune dysfunction, advanced cancer, anti-LAG3, cancer, cell, disintegrin and metalloproteinase domain-containing protein 10, immune dysfunction, inhibitory receptor, intracellular LAG3, patients, peripheral CD8+ T cells, peripheral nave, surface LAG3
Author NameAffiliation
Dhivyaa RajasundaramUniversity of Pittsburgh School of Medicine
Simon C WatkinsUniversity of Pittsburgh School of Medicine
Simon C WatkinsUniversity of Pittsburgh School of Medicine
John M KirkwoodUniversity of Pittsburgh School of Medicine
John M KirkwoodUPMC Hillman Cancer Center
  • 1 - 5

Datasets

Release 1.2